B. Wieringa

Molecular Neurodegeneration · 2017

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom B. Wieringa trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Bryce W. Carey

Papers from B. Wieringa's perspective

Ordered by how strongly the researchers B. Wieringa trusts endorse each paper. Same corpus, a different order for every researcher.

  1. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. (Chinese Medical Journal)
  2. Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells (Journal of Neurochemistry)
  3. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. (Lancet Neurology)
  4. Rotenone, Paraquat, and Parkinson’s Disease (Environmental Health Perspectives)
  5. Quantitative assessment of single-cell RNA-sequencing methods (Nature Methods)
  6. Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells (Nature)
  7. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology (Methods in molecular biology)
  8. Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. (Toxicology in Vitro)
  9. Parkinson disease: from pathology to molecular disease mechanisms. (Free Radical Biology & Medicine)
  10. Epidemiology and etiology of Parkinson’s disease: a review of the evidence (European Journal of Epidemiology)

Their papers